Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524

Q4 FY26 results · Jan–Mar 2026

Rainbow Childrens Medicare reported revenue from operations of ₹459.90 crore (up 24.3% from Q4 FY25) and net profit of ₹78.22 crore (up 38.3% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations459.90370.11+24.3%445.45+3.2%
Other income5.0614.53−65.1%10.51−51.8%
Total income464.96384.63+20.9%455.96+2.0%
Profit before tax86.7976.97+12.8%97.69−11.2%
Net profit for the period78.2256.55+38.3%73.90+5.8%
Attributable to shareholders of the company77.0456.34+36.8%72.53+6.2%
EPS, basic (₹)7.595.55+36.8%7.14+6.3%
Net margin (%)17.015.316.6
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations408.06354.00+15.3%394.35+3.5%
Other income5.2413.89−62.3%10.76−51.3%
Total income413.30367.89+12.3%405.11+2.0%
Profit before tax78.4674.75+5.0%88.43−11.3%
Net profit for the period59.3054.54+8.7%65.82−9.9%
EPS, basic (₹)5.855.37+8.9%6.48−9.7%
Net margin (%)14.515.416.7
Consolidated
Filed with BSE
09 Oct 2026, 19:50 IST
Board meeting
23 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
09 Oct 2026, 19:50 IST
Board meeting
23 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE